Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Income Statement [Abstract]    
Revenues $ 9,911,780 $ 6,428,963
Cost of goods sold 10,248,575 5,503,448
Gross margin (336,795) 925,515
Operating expenses    
Operations 4,411,685 1,353,904
Research and development 5,248,336 2,606,141
Sales and marketing 4,028,007 1,127,532
General and administrative 6,618,596 5,548,589
Stock based compensation 3,656,724 3,291,635
Impairment loss 2,826,918
Total operating expenses 26,790,266 13,927,801
Operating loss (27,127,061) (13,002,286)
Other (income) expense    
Change in fair value of derivative liability (1,019,292) (1,042,129)
Investment income, net (137,787) (355,769)
Interest expense 122,004 147,724
Other, net 995,751 (62,984)
Other (income) expense (39,324) (1,313,158)
Net loss $ (27,087,737) $ (11,689,128)
Loss per share - basic and diluted $ (0.50) $ (0.24)
Weighted average shares outstanding - basic and diluted 53,860,199 48,220,265